Clinical Drug Experience Knowledgebase

allogeneic hematopoietic stem cells (Hemacord) (1 trial)

allogeneic stem cells (4 trials)

Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)

aprepitant (Emend) (1 trial)

arsenic trioxide (trisenox) (1 trial)

artesunate (1 trial)

asparaginase (elspar) (5 trials)

autologous mononuclear stem cell (3 trials)

bone marrow cells (1 trial)

bortezomib (velcade) (14 trials)

caspofungin (cancidas) (1 trial)

cyclophosphamide (cytoxan) (10 trials)

cyclosporine (sandimmune) (1 trial)

cytarabine (cytosar-u) (26 trials)

daunorubicin (cerubidine) (9 trials)

doxorubicin (Doxil) (3 trials)

etoposide (vepesid) (4 trials)

filgrastim (neupogen) (3 trials)

fludarabine (fludara) (8 trials)

gemtuzumab ozogamicin (mylotarg) (1 trial)

granisetron (kytril) (1 trial)

idarubicin (idamycin) (12 trials)

imatinib (gleevec) (3 trials)

interferon alpha-2b (Intron-A) (2 trials)

lenalidomide (revlimid) (9 trials)

mercaptopurine (purinethol) (6 trials)

mitoxantrone (novantrone) (3 trials)

naltrexone (revia) (11 trials)

palonosetron (aloxi) (1 trial)

pegaspargase (oncaspar) (1 trial)

peripheral blood hematopoietic cell (1 trial)

prednisone (meticorten) (16 trials)

pyrimethamine (daraprim) (1 trial)

rituximab (rituxan) (4 trials)

sargramostim (leukine) (5 trials)

sulfadoxine (1 trial)

teniposide (vumon) (1 trial)

thalidomide (Thalomid) (3 trials)

topotecan (hycamtin) (1 trial)

tretinoin (Retin-A) (4 trials)

urea (19 trials)

vincristine (oncovin) (13 trials)

voriconazole (vfend) (1 trial)

zoledronic acid (zometa) (1 trial)

acalabrutinib (calquence) (1 trial)

autologous hematopoietic cell (1 trial)

azacitidine (vidaza) (4 trials)

busulfan (myleran) (1 trial)

carfilzomib (kyprolis) (4 trials)

carmustine (bicnu) (1 trial)

clarithromycin (biaxin) (1 trial)

daratumumab (darzalex) (2 trials)

dexamethasone (6 trials)

ixazomib (ninlaro) (1 trial)

melphalan (alkeran) (8 trials)

pevonedistat (1 trial)

amphotericin b (fungizone) (1 trial)

autologous cd133+ stem cells (1 trial)

belantamab mafodotin (2 trials)

bendamustine (treanda) (1 trial)

beta erythropoietin (1 trial)

blinatumomab (blincyto) (1 trial)

bosutinib (bosulif) (1 trial)

clofarabine (clolar) (1 trial)

dasatinib (sprycel) (1 trial)

filanesib (1 trial)

hydrocortisone (solu-cortef) (1 trial)

ibritumomab tiuxetan (zevalin) (1 trial)

ibrutinib (imbruvica) (1 trial)

idelalisib (zydelig) (1 trial)

ifosfamide (ifex) (1 trial)

methotrexate (1 trial)

panobinostat (farydak) (1 trial)

pembrolizumab (keytruda) (1 trial)

plerixafor (mozobil) (1 trial)

pomalidomide (pomalyst) (2 trials)

ponatinib (iclusig) (1 trial)

quizartinib (3 trials)

selinexor (Xpovio) (2 trials)

valganciclovir (valcyte) (1 trial)

venetoclax (venclexta) (1 trial)

vindesine (1 trial)

elotuzumab (empliciti) (1 trial)

nivolumab (opdivo) (1 trial)

meropenem (merrem) (1 trial)

teicoplanin (1 trial)

vancomycin (Vancocin) (1 trial)